First presentation of data from NEUPRO (rotigotine transdermal patch) Phase 3 study in China announced

UCB has announced efficacy and safety data from a Phase 3 study evaluating NEUPRO® (rotigotine transdermal patch) in the treatment of patients in China with early-stage Parkinson's disease...
Source: Parkinson's Disease News From Medical News Today - Category: Neurology Tags: Parkinson's Disease Source Type: news